Company Profile
  • Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956. In 2000, Hisun issued A-shares in Shanghai stock exchange, but it continues to remain a state-owned enterprise. Hisun is one of the largest antibiotics and anti-tumor drug production bases in the country. 
  • Hisun began as a small chemical factory and entered the pharmaceutical field in the early 1970s. Since its founding over 60 years ago in 1956, Hisun has amassed a total asset worth of 21.8 billion RMB. While Hisun is primarily engaged in the R&D, manufacturing, and sales and marking of API and final dosage forms of chemical and biological drugs, its core business has extended to include branded generic drugs, biosimilarst and other innovative drugs. Today, Hisun operates as a comprehensive biopharmaceutical technology group with multiple business segments in several therapeutic areas, and a full-value chain of R&D, manufacturing, and sales and marketing.

Year of Establishment: 1956

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: "First batch of innovative enterprises"、"National technology innovation demonstration enterprises"、"National Industrial Brand Demonstration Enterprise of the Chinese Ministry of Industry and Information Technology"、“Top Domestic Industrial Manufacturing 500”、“China's top 100 pharmaceutical enterprises"、"Top 100 pharmaceutical international enterprises"、“China's innovative pharmaceutical companies"、“China's top 100 drug research and development"

Send your message to this supplier
  • From:
  • To:
    Zhejiang Hisun Pharma. Co., Ltd.
  • Verification Code:
  • Message:

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now